News

Article

Patheon Doubles Biologics Capacity at St. Louis Facility

Thermo Fisher Scientific invests $50 Million to expand biologics drug development and manufacturing capabilities in St. Louis, MO.

Thermo Fisher Scientific announced in a press statement on April 23, 2018 that is investing $50 million in the Patheon Biologics Center of Excellence (COE) for Biological Commercial Manufacturing in St. Louis, MO, to expand the company’s biologic drug substance capabilities for clinical and commercial supply.

The project includes a 64,000-sq.-ft. expansion to the existing manufacturing building #2 and will feature Thermo Fisher bioproduction bioreactors, consumables, and factory automation. The capacity expansion will double the site’s manufacturing capacity and will give Thermo Fisher the second largest base of single-use bioproduction capacity at a contract development and manufacturing organization in the world, the company reports.

The investment will also allow for further expansion in the future and will add approximately 80 new technical jobs. The company reports the site will be operational in 2019.

The Patheon Biologics Network of four sites has standardized on a 2000L, single-use platform as for new drug development through to commercialization. The St Louis site provides process development, clinical cGMP manufacturing, and commercial manufacturing using fed batch and perfusion processes.

Source: Patheon, part of Thermo Fisher Scientific

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content